e-learning
resources
London 2016
Sunday, 04.09.2016
Human responses to exposure, including physiological and biomarker outcomes
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Lung asbestos content in patients with lung cancer in different Spanish regions. The AMCANES study
Mª Jesus Cruz Carmona (Barcelona, Spain), Mª Jesus Cruz Carmona, Daniel Alvarez-Simón, Roser Costa, Annie Navarro, Ane Uranga, Isabel Urrutia, María-Encarnación Barroso, Belén Marín-Martínez, Jaume Ferrer
Source:
International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Session:
Human responses to exposure, including physiological and biomarker outcomes
Session type:
Poster Discussion
Number:
387
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Mª Jesus Cruz Carmona (Barcelona, Spain), Mª Jesus Cruz Carmona, Daniel Alvarez-Simón, Roser Costa, Annie Navarro, Ane Uranga, Isabel Urrutia, María-Encarnación Barroso, Belén Marín-Martínez, Jaume Ferrer. Lung asbestos content in patients with lung cancer in different Spanish regions. The AMCANES study. Eur Respir J 2016; 48: Suppl. 60, 387
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on Basic translational and clinical research – building a career in paediatric pulmonology- experiences from clinicians in lower middle income countries
ERS/EAACI statement on severe exacerbations in asthma in adults: facts, priorities and key research questions
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Related content which might interest you:
Residential radon and lung cancer histological types in never smokers
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Lung cancer in never smokers. A survival analysis in a radon prone area
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
Residential radon exposure and risk of lung cancer in never smoking women
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Interstitial lung diseases associated with lung cancer
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Lung cancer in women: Is it different?
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Evaluation of lung cancer patients with distant organ metastasis
Source: International Congress 2014 – Therapy of thoracic tumours: clinical trials and case series
Year: 2014
Co-exposure between asbestos and inorganic particles and risk of lung cancer in the ARDCO study
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016
Incidence of interstitial lung disease (ILD) and risk factors for developing ILD: A final analysis of a large-scale erlotinib Japanese surveillance study in non-small-cell lung cancer (NSCLC)
Source: Annual Congress 2013 –Connective tissue disease and interstitial lung disease
Year: 2013
The combination of lung cancer and bauxite pneumoconiosis on resection of lung
Source: International Congress 2016 – Epidemiology and specific subgroups in lung cancer
Year: 2016
Prevalence of COPD and emphysema at the time of diagnosis of primary lung cancer
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
Incidence of lung cancer in smokers with and without COPD: Observational study
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
VOC analysis in headspace air of mesothelioma and lung cancer cell lines: A comparative literature study
Source: International Congress 2016 – Mesothelioma and malignant pleural disease
Year: 2016
Weight loss cutoff level as a key variable related to death risk among advanced lung cancer patients
Source: International Congress 2014 – Epidemiology, pathogenesis and quality management of thoracic tumours
Year: 2014
General characteristics and therapeutic options in lung cancer in Turkey
Source: International Congress 2015 – Thoracic oncology around the world: rare cases and local features
Year: 2015
A feasibility study of pulmonary rehabilitation at home in patients with lung cancer or malignant pleural mesothelioma treated by (radio-)chemotherapy
Source: International Congress 2014 – Best abstracts in pulmonary rehabilitation and exercise training
Year: 2014
Lung diseases infection and risk of lung cancer
Source: Annual Congress 2013 –Pathogenesis and risk of lung cancer
Year: 2013
Is the lung cancer in elderly similar to lung cancer in younger patients?
Source: International Congress 2014 – The epidemiology of respiratory infections and lung cancer
Year: 2014
Lung cancer and lung tuberculosis: Our results of treatment in the combined lung disease
Source: International Congress 2016 – Surgical strategy for complex diseases
Year: 2016
EGFR mutation in non-small cell lung cancer(NSCLC) in South Croatia
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
Does bronchial location of lung cancer influence overall survival?
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept